Infections Clinical Trials in Bethesda, Maryland
13 recruitingBethesda, Maryland
Showing 1–13 of 13 trials
Recruiting
Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)
PneumoniaInfectionsImmune System Diseases+2 more
National Institute of Allergy and Infectious Diseases (NIAID)600 enrolled1 locationNCT00006150
Recruiting
Phase 1Phase 2
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
NeutropeniaInfectionsWarts+2 more
National Institute of Allergy and Infectious Diseases (NIAID)20 enrolled1 locationNCT00967785
Recruiting
Modeling Host-Pathogen Interaction Using Lymphoid Organoids
Staphylococcal Infections
National Institute of Allergy and Infectious Diseases (NIAID)500 enrolled2 locationsNCT06479837
Recruiting
Diagnosis and Treatment of Leishmania Infections
LeishmaniasisSkin Diseases, ParasiticEuglenozoa Infections+1 more
National Institute of Allergy and Infectious Diseases (NIAID)289 enrolled1 locationNCT00344188
Recruiting
Studies of Disorders With Increased Susceptibility to Fungal Infections
Fungal infectionsPrimary Immune Deficiencies
National Institute of Allergy and Infectious Diseases (NIAID)850 enrolled1 locationNCT01222741
Recruiting
Study of Mycobacterial Infections
Mycobacterium Infections
National Institute of Allergy and Infectious Diseases (NIAID)1,000 enrolled1 locationNCT00018044
Recruiting
Natural History of Anthrax: a Study of Primary Infected, Recovered, and Exposed Individuals (SPoRE); and Evaluation of AVA-Vaccinated Recipients
AnthraxBacillus Infections
National Institute of Allergy and Infectious Diseases (NIAID)200 enrolled1 locationNCT00050310
Recruiting
Phase 2
Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
LymphomaEpstein-Barr Virus InfectionsLymphoproliferative Disorder+1 more
National Cancer Institute (NCI)40 enrolled1 locationNCT03258567
Recruiting
Training Protocol on the Natural History of Tuberculosis
TuberculosisLatent TuberculosisMycobacterium Infections+2 more
National Institute of Allergy and Infectious Diseases (NIAID)150 enrolled1 locationNCT01212003
Recruiting
Phase 3
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
Non-Hodgkin LymphomaBacterial InfectionsHypogammaglobulinemia+2 more
Grifols Therapeutics LLC386 enrolled62 locationsNCT05645107
Recruiting
Phase 1Phase 2
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Advanced Solid TumorsCarcinomaNeoplasms+9 more
Marengo Therapeutics, Inc.365 enrolled32 locationsNCT05592626
Recruiting
X-linked Moesin Associated Immunodeficiency
DiagnosisInfectionsImmune Deficiency+1 more
Institut National de la Santé Et de la Recherche Médicale, France16 enrolled10 locationsNCT06278337
Recruiting
Not Applicable
Evaluation of the SafeSpace App Intervention
Health BehaviorHealth Care UtilizationSexually Transmitted Infections+1 more
Child Trends1,000 enrolled1 locationNCT06043596